78 related articles for article (PubMed ID: 15668111)
1. Reaction-kinetic parameters of glycidamide as determinants of mutagenic potency.
Silvari V; Haglund J; Jenssen D; Golding BT; Ehrenberg L; Törnqvist M
Mutat Res; 2005 Feb; 580(1-2):91-101. PubMed ID: 15668111
[TBL] [Abstract][Full Text] [Related]
2. Reaction kinetic studies for comparison of mutagenic potency between butadiene monoxide and glycidamide.
Motwani HV; Eriksson L; Göpfert L; Larsen K
Chem Biol Interact; 2018 May; 288():57-64. PubMed ID: 29653098
[TBL] [Abstract][Full Text] [Related]
3. Quantification of the mutagenic potency and repair of glycidol-induced DNA lesions.
Aasa J; Vare D; Motwani HV; Jenssen D; Törnqvist M
Mutat Res Genet Toxicol Environ Mutagen; 2016 Jul; 805():38-45. PubMed ID: 27402481
[TBL] [Abstract][Full Text] [Related]
4. Genotoxicity of glycidamide in comparison to 3-N-nitroso-oxazolidin-2-one.
Baum M; Loeppky RN; Thielen S; Eisenbrand G
J Agric Food Chem; 2008 Aug; 56(15):5989-93. PubMed ID: 18624445
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis by liquid chromatography-tandem mass spectrometry of glycidamide using the cob(I)alamin trapping method: validation and application to in vitro metabolism of acrylamide.
Motwani HV; Törnqvist M
J Chromatogr A; 2011 Jul; 1218(28):4389-94. PubMed ID: 21652039
[TBL] [Abstract][Full Text] [Related]
6. Mutagenic activity of ethylene oxide and propylene oxide under XPG proficient and deficient conditions in relation to N-7-(2-hydroxyalkyl)guanine levels in Drosophila.
Nivard MJ; Czene K; Segerbäck D; Vogel EW
Mutat Res; 2003 Aug; 529(1-2):95-107. PubMed ID: 12943923
[TBL] [Abstract][Full Text] [Related]
7. Acrylamide and glycidamide: genotoxic effects in V79-cells and human blood.
Baum M; Fauth E; Fritzen S; Herrmann A; Mertes P; Merz K; Rudolphi M; Zankl H; Eisenbrand G
Mutat Res; 2005 Feb; 580(1-2):61-9. PubMed ID: 15668108
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic damage induced by acrylamide and glycidamide in mammalian cells: correlation with specific glycidamide-DNA adducts.
Martins C; Oliveira NG; Pingarilho M; Gamboa da Costa G; Martins V; Marques MM; Beland FA; Churchwell MI; Doerge DR; Rueff J; Gaspar JF
Toxicol Sci; 2007 Feb; 95(2):383-90. PubMed ID: 17088317
[TBL] [Abstract][Full Text] [Related]
9. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
10. Mutagenicity and DNA repair of glycidamide-induced adducts in mammalian cells.
Johansson F; Lundell T; Rydberg P; Erixon K; Jenssen D
Mutat Res; 2005 Feb; 580(1-2):81-9. PubMed ID: 15668110
[TBL] [Abstract][Full Text] [Related]
11. Relationships between biomarkers of exposure and toxicokinetics in Fischer 344 rats and B6C3F1 mice administered single doses of acrylamide and glycidamide and multiple doses of acrylamide.
Tareke E; Twaddle NC; McDaniel LP; Churchwell MI; Young JF; Doerge DR
Toxicol Appl Pharmacol; 2006 Nov; 217(1):63-75. PubMed ID: 17007897
[TBL] [Abstract][Full Text] [Related]
12. Genotoxic effects of inhaled ethylene oxide, propylene oxide and butylene oxide on germ cells: sensitivity of genetic endpoints in relation to dose and repair status.
Vogel EW; Nivard MJ
Mutat Res; 1998 Sep; 405(2):259-71. PubMed ID: 9748619
[TBL] [Abstract][Full Text] [Related]
13. Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites in human cells.
Meng RQ; Hackfeld LC; Hedge RP; Wisse LA; Redetzke DL; Walker VE;
Res Rep Health Eff Inst; 2010 Jun; (150):1-34; discussion 35-41. PubMed ID: 20853577
[TBL] [Abstract][Full Text] [Related]
14. Acrylamide and glycidamide: approach towards risk assessment based on biomarker guided dosimetry of genotoxic/mutagenic effects in human blood.
Baum M; Fauth E; Fritzen S; Herrmann A; Mertes P; Rudolphi M; Spormann T; Zankl H; Eisenbrand G; Bertow D
Adv Exp Med Biol; 2005; 561():77-88. PubMed ID: 16438290
[TBL] [Abstract][Full Text] [Related]
15. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
Motwani HV; Törnqvist M
Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
[TBL] [Abstract][Full Text] [Related]
16. DNA strand breaking capacity of acrylamide and glycidamide in mammalian cells.
Puppel N; Tjaden Z; Fueller F; Marko D
Mutat Res; 2005 Feb; 580(1-2):71-80. PubMed ID: 15668109
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of acrylamide to glycidamide and their cytotoxicity in isolated rat hepatocytes: protective effects of GSH precursors.
Kurebayashi H; Ohno Y
Arch Toxicol; 2006 Dec; 80(12):820-8. PubMed ID: 16699760
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the adducts formed in the reactions of glycidamide with thymidine and cytidine.
Backman J; Sjöholm R; Kronberg L
Chem Res Toxicol; 2004 Dec; 17(12):1652-8. PubMed ID: 15606141
[TBL] [Abstract][Full Text] [Related]
19. Comparison of genotoxic potency of styrene 7,8-oxide with gamma radiation and human cancer risk estimation of styrene using the rad-equivalence approach.
Godderis L; Aka P; Kirsch-Volders M; Veulemans H
Mutagenesis; 2007 May; 22(3):209-15. PubMed ID: 17311804
[TBL] [Abstract][Full Text] [Related]
20. Genotoxicity of stereoisomers of 1,2,3,4-diepoxybutane in the gpt gene of Chinese hamster ovary AS52 cells.
Kim MY
Bull Environ Contam Toxicol; 2011 Jun; 86(6):587-90. PubMed ID: 21516456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
